Trastuzumab Plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer
New England Journal of Medicine - United States
doi 10.1056/nejmoa052122
Full Text
Open PDFAbstract
Available in full text
Categories
Date
October 20, 2005
Authors
Publisher
Massachusetts Medical Society